Numis Securities restated their add rating on shares of Diploma (LON:DPLM) in a report published on Monday morning.

A number of other research firms have also recently commented on DPLM. Peel Hunt upped their price target on shares of Diploma from GBX 1,200 ($16.28) to GBX 1,300 ($17.63) and gave the stock an add rating in a report on Monday. Berenberg Bank restated a buy rating and issued a GBX 1,365 ($18.52) price target on shares of Diploma in a report on Monday, March 12th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Diploma currently has a consensus rating of Hold and an average price target of GBX 1,279 ($17.35).

LON DPLM opened at GBX 1,235 ($16.75) on Monday. Diploma has a 12 month low of GBX 1,010 ($13.70) and a 12 month high of GBX 1,270 ($17.23).

Diploma (LON:DPLM) last posted its quarterly earnings results on Monday, May 14th. The company reported GBX 26.70 ($0.36) EPS for the quarter, topping the Zacks’ consensus estimate of GBX 26.30 ($0.36) by GBX 0.40 ($0.01). Diploma had a net margin of 10.32% and a return on equity of 18.70%.

The firm also recently announced a dividend, which will be paid on Wednesday, June 13th. Shareholders of record on Thursday, May 24th will be issued a dividend of GBX 7.70 ($0.10) per share. This represents a yield of 0.62%. The ex-dividend date of this dividend is Thursday, May 24th.

In other Diploma news, insider John Edward Nicholas bought 2,000 shares of the company’s stock in a transaction on Tuesday, May 15th. The shares were bought at an average cost of GBX 1,247 ($16.92) per share, for a total transaction of £24,940 ($33,830.71).

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in North America, Europe, and internationally. It operates through Life Sciences, Seals, and Controls business sectors. The Life Sciences sector supplies consumables and instruments for the diagnostic testing of blood, tissue, and other samples in hospital pathology laboratories; electrosurgery equipment and consumables for use in hospital operating rooms; and surgical medical devices, and related consumables and services to GI endoscopy suites in hospitals and private clinics.

Analyst Recommendations for Diploma (LON:DPLM)

Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.